This inventor holds 10 USPTO granted patents. Top assignees: Becton Dickinson and Company Limited, Nexstar Pharmaceuticals, Inc.. Active years: 1997-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Los Altos, CA (US) (1997 - 1999)
- Woodside, CA (US) (1999 - 2002)
- Mountain View, CA (US) (2001 - 2007)
Company Filing History:
9 out of 5,412 
1 out of 131 Years Active: 1997-2007
Title: Innovations by Kenneth A Davis: A Pioneer in Immunology
Introduction
Kenneth A Davis is a notable inventor based in Mountain View, California. With a portfolio of 10 patents, he has made significant contributions to the field of immunology. His work focuses on developing methods and compounds that enhance the detection and understanding of immune responses, particularly involving T lymphocytes.
Latest Patents
Among his latest patents is the development of intrinsically fluorescent, self-multimerizing MHC fusion proteins and complexes. This innovation facilitates the detectable labeling of antigen-specific T lymphocytes, streamlining methods for their detection, enumeration, enrichment, and depletion. Moreover, his patent on improved methods, reagents, and kits for quantifying cell-surface molecule expression, specifically HLA-DR and CD11b on peripheral blood cells, showcases his dedication to advancing immune competence assessment. Key features of these methods include the use of lysosomotropic amines to stabilize expression levels and a novel anti-CD14 conjugate that enhances monocyte differentiation.
Career Highlights
Kenneth has held significant roles in prominent companies such as Becton Dickinson and Company Limited and Nexstar Pharmaceuticals, Inc. His contributions in these organizations reflect a deep commitment to harnessing scientific innovations to improve healthcare outcomes through better understanding of immune responses.
Collaborations
Throughout his career, Kenneth has collaborated with esteemed peers including James E Bishop and Barnaby Abrams. These partnerships have likely fostered groundbreaking advancements in immunology, demonstrating the power of collaborative innovation in research and development.
Conclusion
Kenneth A Davis stands out as an influential inventor in the realm of immunology, with a robust patent portfolio that impacts the detection and understanding of T lymphocytes. His innovative approaches and collaborations facilitate advancements in medical science, paving the way for improved therapeutic strategies and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile